Skip to Main Content
Boston University
  • Bostonia
  • BU Today
  • The Brink
  • University Publications

    • Bostonia
    • BU Today
    • The Brink
  • School & College Publications

    • The Record
Other Publications
BU Today
  • Sections
News, Opinion, Community

Leading scientists meet to discuss treatment of Alzheimer’s disease

Symposium tomorrow open to the public

Affecting an estimated 18 million people worldwide, Alzheimer’s disease (AD) carries an economic burden in excess of $100 billion a year in the United States alone. In an effort to bring together leading scientists from academia and industry to discuss the latest findings and strategies in dealing with the disease, the School of Medicine and Wyeth Research are presenting the Wyeth Symposium in the Pharmacological Sciences: Understanding Mechanisms Important in Neurodegeneration and Regeneration of the Nervous System.

This daylong program will be held tomorrow, Thursday, November 10, at the Trustee Ballroom on the ninth floor of One Sherborn St., beginning at 8:30 a.m. The event is free and open to the public.

This international symposium of leaders in the research of neurodegenerative disorders was organized by David H. Farb, chairman of MED’s department of pharmacology and experimental therapeutics and director of the Interdepartmental Program in BioMedical Neuroscience, in collaboration with Menelas N. Pangalos, vice president of neuroscience research at Wyeth Research, and Steve Projan, vice president of biological technologies at Wyeth Research.

Currently, medication is available to treat some of the symptoms of Alzheimer’s for a brief period of time. “Therapies that halt or reverse the disease progression of AD is a major area of focus across the academic, biotechnology, and pharmaceutical communities,” says Farb. “This symposium will provide the opportunity for discussion on the latest findings and strategies that are being employed to treat not only the symptoms, but also the underlying disease pathology.”

The morning session will focus specifically on the latest discoveries in understanding the biology of neuronal cell death, as well as strategies to develop therapies that modify the associated symptoms, such as memory impairment. The second session will focus on the latest findings regarding the biology of neuronal cell growth and survival and the potential strategies that might one day result in therapies to stop or even reverse the neuronal cell loss associated with AD and other degenerative disorders.

The symposium offers an opportunity for students, researchers, and the general public to hear from some of the most prominent scientists in the field and to learn more about the science that is pushing the boundaries for future therapies for Alzheimer’s and other neurodegenerative diseases.

Wyeth Research provided an unrestricted grant to support the conference.

Explore Related Topics:

  • Global
  • Research
  • Share this story

Share

Leading scientists meet to discuss treatment of Alzheimer’s disease

Share

  • Twitter
  • Facebook
  • Reddit
  • LinkedIn
  • Email

Latest from BU Today

  • University News

    Boston University to Seek External Recommendations for Athletics Policies and Practices

  • University News

    BU’s Jack Parker Elected to the Hockey Hall of Fame

  • BU Soundcheck

    BU Soundcheck: Ronona J

  • Film & TV

    COM Students Win New England Emmy Award for 2024 BUTV10 Election Coverage

  • Watch Now

    How BU’s Lawns Can Help Reduce Carbon Emissions

  • Awards

    Meet BU’s Newest Fulbright Recipients

  • Film

    Where to Watch Free Movies Outdoors All Summer Long

  • University News

    BU Opens Cooling Stations as First Heat Wave of the Season Arrives

  • Photography

    Photo Essay: A Look Back at Spring on Campus

  • University News

    BU Rises in New Rankings of World Universities and Cited as a Digital Leader in Higher Education

  • Film

    Getting to Know Your Neighborhood: Central Square

  • Music

    Drumroll, Please, for CFA’s Gareth Smith

  • JUNETEENTH

    Celebrating Juneteenth Around Boston

  • University News

    BU Backs Lawsuit to Halt Cuts to Department of Defense Research Funding

  • Obituaries

    Minnesota State Representative Melissa Hortman, a Boston University Alum, Shot and Killed Along with Her Husband

  • EDUCATION

    The Power of the Middle School Years

  • Film & TV

    From Superman to F1, Expect a Summer of Blockbusters

  • Social Media

    YouTube Is the Latest Media Platform to Loosen Content Moderation. What Does That Mean for Users?

  • Wellness

    In Honor of Father’s Day, 5 Foods That All Men Need in Their Diet

  • University News

    Supporting Boston University’s International Community—Q&A with President Melissa Gilliam and Willis Wang, Head of Global Operations

Section navigation

  • Sections
  • Must Reads
  • Videos
  • Series
  • Close-ups
  • Archives
  • About + Contact
Get Our Email

Explore Our Publications

Bostonia

Boston University’s Alumni Magazine

BU Today

News, Opinion, Community

The Brink

Pioneering Research from Boston University

  • Twitter
  • Facebook
  • Youtube
  • LinkedIn
  • Instagram
  • Weibo
  • TikTok
© Boston University. All rights reserved. www.bu.edu
© 2025 Trustees of Boston UniversityPrivacy StatementAccessibility
Boston University
Notice of Non-Discrimination: Boston University prohibits discrimination and harassment on the basis of race, color, natural or protective hairstyle, religion, sex or gender, age, national origin, ethnicity, shared ancestry and ethnic characteristics, physical or mental disability, sexual orientation, gender identity and/or expression, genetic information, pregnancy or pregnancy-related condition, military service, marital, parental, veteran status, or any other legally protected status in any and all educational programs or activities operated by Boston University. Retaliation is also prohibited. Please refer questions or concerns about Title IX, discrimination based on any other status protected by law or BU policy, or retaliation to Boston University’s Executive Director of Equal Opportunity/Title IX Coordinator, at titleix@bu.edu or (617) 358-1796. Read Boston University’s full Notice of Nondiscrimination.
Search
Boston University Masterplate
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Leading scientists meet to discuss treatment of Alzheimer’s disease
0
share this